Dr. Einzig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1695 Eastchester Rd
Ste 304
Bronx, NY 10461Phone+1 718-822-4432Fax+1 718-822-4738
Education & Training
Memorial Sloan Kettering Cancer CenterImmunology, 1981 - 1984
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1978 - 1981
Albert Einstein College of MedicineClass of 1978
Certifications & Licensure
NY State Medical License 1979 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.Sung Ho Lee, Lool Abebe, Elisabeth Paietta, Avi I. Einzig, Peter H. Wiernik
American Journal of Hematology. 2009-07-01 - 78 citationsPhase II Trial of Infusional Cyclophosphamide, Doxorubicin, and Etoposide in Patients With HIV-Associated Non-Hodgkin’s Lymphoma: An Eastern Cooperative Oncology Group...Joseph A. Sparano, Sandra J. Lee, Michael G. Chen, Tipu Nazeer, Avi Einzig
Journal of Clinical Oncology. 2004-04-15 - 11 citationsCarboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study.Sakkaraiappan Ramalingam, T. Dobbs, Avi I. Einzig, Slawomir Wojtowicz-Praga, Marianne Cascino
Cancer Chemotherapy and Pharmacology. 2004-01-27
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
